Ami Fadia
Stock Analyst at Needham
(0)
# 3187
Out of 5,240 analysts
426
Total ratings
40.26%
Success rate
3.79%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Immuneering | Reiterates: Buy | 15 15 | 1.96 | 665.31% | 12 | Jan 13, 2025 | |
Day One Biopharmaceu... | Reiterates: Buy | 33 33 | 11.16 | 195.7% | 18 | Jan 13, 2025 | |
Harmony Biosciences | Reiterates: Buy | 52 52 | 36.42 | 42.78% | 30 | Jan 13, 2025 | |
Intra-Cellular Thera... | Downgrades: Hold | 100 100 | 126.84 | -21.16% | 26 | Jan 13, 2025 | |
Bicycle Therapeutics | Reiterates: Buy | 32 32 | 14.82 | 115.92% | 16 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 133 133 | 84.66 | 57.1% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 135 135 | 102.53 | 31.67% | 26 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 19 | 8.03 | 136.61% | 32 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 23 | 2.25 | 922.22% | 6 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 11 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 207 207 | 123.1 | 68.16% | 26 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 15 15 | 7.41 | 102.43% | 21 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 39 | 117.95% | 25 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 62 | 39.85 | 55.58% | 20 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 18 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 270 270 | 143 | 88.81% | 36 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 28 | 16.89 | 65.78% | 6 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 151 151 | 66 | 128.79% | 7 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 6 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 7 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | n/a | n/a | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 28 26 | n/a | n/a | 6 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 16 | 0.51 | 3037.25% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 63 75 | 20.55 | 264.96% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 5 | n/a | n/a | 2 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 10 14 | n/a | n/a | 3 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 23 | 1.6 | 1306.25% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 63 | 23.51 | 167.97% | 4 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 2 | n/a | n/a | 8 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 10 | n/a | n/a | 2 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 24 | n/a | n/a | 8 | Jan 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 20 | n/a | n/a | 2 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 5 | 3.42 | 46.2% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 7 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | n/a | n/a | 5 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 1.47 | 1396.6% | 4 | Jan 3, 2018 |